PRINCE HARRY LEAVES AFRICAN PARKS BOARD AFTER CHARITY ADMITTED RANGERS COMMITTED HUMAN RIGHTS ABUSES. (PHOTO).
Prince Harry leaves African Parks board after charity admitted rangers committed human rights abuses Prince Harry has left the board of African Parks after nearly a decade with the conservation charity, a year after the organization acknowledged that some of its rangers had committed human rights abuses. A spokesperson for Harry, 41, confirmed his departure while emphasizing that his work in African conservation will continue. “The Duke is proud of his 10 years with African Parks and fully supports the ongoing strengthening of its Board,” the spokesperson said. “His commitment to conservation in Africa continues, and he remains a supporter of African Parks’ mission.” Harry first partnered with African Parks in 2016 and became president of the organization the following year. He was appointed to its board of directors in 2023. His departure comes after African Parks commissioned an independent investigation into allegations that rangers had r@ped, beaten and tortured Indigenous peo...
It was reported today wednesday that a vaccine against HIV will be trailed in South Africa later this year 2016 after it met the criteria needed to prove it could help fight the epidemic in Africa.A small trial,known as HVTN100,initially took place in South Africa in 2015 to test the safety and strength of Immunity the vaccine could provide,ahead of any large-scale testing in affected populations.Two hundred and fifty two healthy volunteers were enrolled to receive either the vaccine,known as ALVAC-HIV/gp120,or a placebo to compare the extent of immune response generated.The results were presented Tuesday at the 21st International AIDS Conference in Durban,South Africa.''Thos was precautionary to see if the vaccine looks promising'',CNN reports Linda Gail Bekker,deputy director of the Desmond Tutu HIV Centre in Cape Town,South Africa,and president-elect of the International AIDS Society,who is leading the vaccine trials,as saying.The vaccine stems from a landmark trial in Thailand in 2009 that was the first to show any protection against HIV,with 31% protection against the virus.This was enough to get experts in the field excited after years with no success.The vaccine was improved for use in the higher-risk populations of sub-Saharan Africa,where a different subtype of the virus also exits.5,400 people across four sites in South Africa will receive the vaccine in November and run for three years.One more photo below. 
Comments
Post a Comment